What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement
QI Medical

Microbial Identification: How to Comply with Current and Future Versions of USP Chapter

WEBINAR

Microbial Identification: How to Comply with Current and Future Versions of USP Chapter <797>

July 22, 2020 | 1:00 PM EDT

WITH

Abby Roth 

Senior Director of Business Operations

CriticalPoint, LLC

RESERVE YOUR SEAT


Microbial identification to the genus level provides valuable insight into the origin of the recovered microorganism. However, the June 2019 revision to Chapter <797> made genus-level ID required for sterile compounding only when the count exceeds the action level. This change makes sense for microorganisms recovered from a less controlled area, such as an anteroom. However, the chapter does not distinguish between those areas and spaces like an ISO Class 5 cleanroom, which has raised some questions about when and when not to perform genus-level ID.


Join us as we address those concerns and discuss other topics about how changes to Chapter <797> affect microbial ID, including: 

  • What genus-level identification entails, and why Gram stains are insufficient to accomplish this
  • Current and future requirements for microbial identification
  • Importance of microbial identifications and remediation of exceeded action levels


We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.


Scheduling conflict? Sign up and we’ll share the webinar on demand.

Charles River

Charles River News & Announcements

In today’s world, quality and compliance are non-negotiable, and yesterday’s standards are no longer sufficient to meet the demands of a constantly evolving landscape. The field of quality control microbiology is undergoing a disruptive revolution to safeguard patient safety, evolving beyond traditional methods to optimize resources, minimize human error, enable sustainable alternatives, and maintain consistent quality standards. Every test, every result, and every data point define the success of life-changing therapies. That’s why we’re leading a new paradigm, one that redefines efficiency, sustainability, and innovation. Let’s rethink the future of microbial quality control, where modern, automated, data-centric, and scalable solutions are the norm, empowering you to stay ahead in a dynamic regulatory and operational landscape.  Together, we are not just preparing for the future. We’re rethinking it. Because every moment matters.

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from Microbial Identification: How to Comply with Current and Future Versions of USP Chapter

Name
Address
Subscribe